182 related articles for article (PubMed ID: 35788731)
1. ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications.
Belcher SM; Mackler E; Muluneh B; Ginex PK; Anderson MK; Bettencourt E; DasGupta RK; Elliott J; Hall E; Karlin M; Kostoff D; Marshall VK; Millisor VE; Molnar M; Schneider SM; Tipton J; Yackzan S; LeFebvre KB; Sivakumaran K; Waseem H; Morgan RL
Oncol Nurs Forum; 2022 Jun; 49(4):279-295. PubMed ID: 35788731
[TBL] [Abstract][Full Text] [Related]
2. ONS Guidelines™ for Cancer Treatment-Related Radiodermatitis.
Gosselin T; Ginex PK; Backler C; Bruce SD; Hutton A; Marquez CM; McGee LA; Shaftic AM; Suarez LV; Moriarty KA; Maloney C; Vrabel M; Morgan RL
Oncol Nurs Forum; 2020 Nov; 47(6):654-670. PubMed ID: 33063779
[TBL] [Abstract][Full Text] [Related]
3. Interventions to Support Adherence to Oral Anticancer Medications: Systematic Review and Meta-Analysis.
Waseem H; Ginex PK; Sivakumaran K; DeGennaro GM; Lagler-Clark S; LeFebvre KB; Palmer N; Pasumarthi T; Rieger P; Thoele K; Morgan RL
Oncol Nurs Forum; 2022 Jun; 49(4):E4-E16. PubMed ID: 35788733
[TBL] [Abstract][Full Text] [Related]
4. ONS Guidelines™ for Cancer Treatment-Related Skin Toxicity.
Williams LA; Ginex PK; Ebanks GL; Ganstwig K; Ciccolini K; Kwong BK; Robison J; Shelton G; Strelo J; Wiley K; Maloney C; Moriarty KA; Vrabel M; Morgan RL
Oncol Nurs Forum; 2020 Sep; 47(5):539-556. PubMed ID: 32830806
[TBL] [Abstract][Full Text] [Related]
5. Domains of Structured Oral Anticancer Medication Programs: A Scoping Review.
Sivakumaran K; Ginex PK; Waseem H; Belcher SM; Lagler-Clark S; LeFebvre KB; Palmer N; Pasumarthi T; Morgan RL
Oncol Nurs Forum; 2022 Jun; 49(4):296-306. PubMed ID: 35788732
[TBL] [Abstract][Full Text] [Related]
6. ONS Guidelines™ for Opioid-Induced and Non-Opioid-Related Cancer Constipation.
Rogers B; Ginex PK; Anbari A; Hanson BJ; LeFebvre KB; Lopez R; Thorpe DM; Wolles B; Moriarty KA; Maloney C; Vrabel M; Morgan RL
Oncol Nurs Forum; 2020 Nov; 47(6):671-691. PubMed ID: 33063786
[TBL] [Abstract][Full Text] [Related]
7. A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.
Schneider MP; Achtari Jeanneret L; Chevaux B; Backes C; Wagner AD; Bugnon O; Luthi F; Locatelli I
Front Pharmacol; 2018; 9():1567. PubMed ID: 30761009
[No Abstract] [Full Text] [Related]
8. ONS Guidelines™ for Cancer Treatment-Related Lymphedema.
Armer JM; Ostby PL; Ginex PK; Beck M; Deng J; Fu MR; Lasinski BB; Lockwood S; Poage E; White J; Maloney C; Moriarty KA; Vrabel M; Morgan RL
Oncol Nurs Forum; 2020 Sep; 47(5):518-538. PubMed ID: 32830794
[TBL] [Abstract][Full Text] [Related]
9. Current management of adults receiving oral anti-cancer medications: A scoping review.
Richmond JP; Kelly MG; Johnston A; Murphy PJ; Murphy AW
Eur J Oncol Nurs; 2021 Oct; 54():102015. PubMed ID: 34500319
[TBL] [Abstract][Full Text] [Related]
10. Patient-mediated interventions to improve professional practice.
Fønhus MS; Dalsbø TK; Johansen M; Fretheim A; Skirbekk H; Flottorp SA
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012472. PubMed ID: 30204235
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
.
Atkinson TM; Rodríguez VM; Gordon M; Avildsen IK; Emanu JC; Jewell ST; Anselmi KA; Ginex PK
Oncol Nurs Forum; 2016 Sep; 43(5):576-82. PubMed ID: 27541550
[TBL] [Abstract][Full Text] [Related]
12. Interventions for involving older patients with multi-morbidity in decision-making during primary care consultations.
Butterworth JE; Hays R; McDonagh ST; Richards SH; Bower P; Campbell J
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684697
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Provider Adherence to Recommended Monitoring Parameters for Oral Anticancer Medications.
Redelico TJ; Walton SM; LaFollette J; Adams Curry M; Bernal-Mizrachi L
J Oncol Pract; 2018 Jul; 14(7):e446-e450. PubMed ID: 29813011
[TBL] [Abstract][Full Text] [Related]
15. Adherence to Oral Anticancer Medications: Evolving Interprofessional Roles and Pharmacist Workforce Considerations.
Paolella GA; Boyd AD; Wirth SM; Cuellar S; Venepalli NK; Crawford SY
Pharmacy (Basel); 2018 Mar; 6(1):. PubMed ID: 29518017
[TBL] [Abstract][Full Text] [Related]
16. Adherence to Oral Anticancer Medications Among Women With Breast Cancer in Africa: A Scoping Review.
Onwusah DO; Ojewole EB; Chimbari MJ
JCO Glob Oncol; 2023 Jan; 9():e2100289. PubMed ID: 36689700
[TBL] [Abstract][Full Text] [Related]
17. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications.
Cross AJ; Elliott RA; Petrie K; Kuruvilla L; George J
Cochrane Database Syst Rev; 2020 May; 5(5):CD012419. PubMed ID: 32383493
[TBL] [Abstract][Full Text] [Related]
18. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
19. Adherence to Oral Anticancer Medications After Implementation of an Ambulatory Adherence Program at a Large Urban Academic Hospital.
Curry MA; Chineke I; Redelico T; Terrell C; Bell W; Flood D; Mishra P; LaFollette J; Power S; Bernal-Mizrachi L
JCO Oncol Pract; 2020 Apr; 16(4):e350-e356. PubMed ID: 32048938
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
